Patent Assignment
Reel/Frame 066645/0172
Assignment of Assignor's Interest
Recorded: 2024-02-22
Pages: 140
Assignee
INCYTE CORPORATION
1801 AUGUSTINE CUT-OFF, WILMINGTON, DELAWARE, 19803
Covered Properties
(21)
Combination Therapy with an Anti - CD19 Antibody and a Nitrogen Mustard
Application:
14/126,928 →
Publication:
US 2014/0255427
Combinations and Uses Thereof
Application:
16/839,777 →
Publication:
US 2020/0353077
Combinations and Uses Thereof
Application:
18/411,350 →
Publication:
US 2024/0366756
Combination therapy with an anti-CD19 antibody and a purine analog
Application:
14/127,217 →
Publication:
US 2014/0227277
Combinations and Uses Thereof
Application:
16/839,903 →
Publication:
US 2020/0352975
Combinations and Uses Thereof
Combinations and Uses Thereof
Combination of an Anti-CD19 Antibody and a Bruton's Tyrosine Kinase Inhibitor and Uses Thereof
Combination of an Anti-CD19 Antibody and a Bruton's Tyrosine Kinase Inhibitor and Uses Thereof
Application:
16/806,353 →
Publication:
US 2020/0206228
Combination of an Anti-CD19 Antibody and a Bruton's Tyrosine Kinase Inhibitor and Uses Thereof
Application:
18/162,955 →
Publication:
US 2024/0009196
Anti-CD19 Antibody Formulations
Anti-CD19 Antibody Formulations
Application:
17/700,809 →
Publication:
US 2022/0213190
Methods for Predicting Therapeutic Benefit of Anti-CD19 Therapy in Patients
Application:
16/305,482 →
Publication:
US 2019/0195879
Methods for Predicting Therapeutic Benefit of Anti-CD19 Therapy in Patients
Combination of Anti CD19 Antibody with a Bcl-2 Inhibitor and Uses Thereof
Treatment Paradigm for an Anti-CD19 Antibody and Venetoclax Combination Treatment
Application:
16/615,953 →
Publication:
US 2021/0292410
Anti-CD19 Therapy in Patients Having a Limited Number of Nk Cells
Application:
17/605,285 →
Publication:
US 2022/0242952
Anti-CD19 Therapy in Combination with Lenalidomide for the Treatment of Leukemia or Lymphoma
Application:
17/084,751 →
Publication:
US 2021/0130460
Anti-Tumor Combination Therapy Comprising Anti-CD19 Antibody and Gamma Delta T-Cells
Application:
17/084,783 →
Publication:
US 2021/0130461
Sequential Anti-CD19 Therapy
Application:
17/773,117 →
Publication:
US 2024/0156863
Treatment Paradigm for an Anti-CD19 Antibody Therapy
Application:
18/087,068 →
Publication:
US 2023/0357392
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 17, 2013
From: AMERSDORFFER, JUTTA, DR; STEIDL, STEFAN, DR; WINDERLICH, MARK, DR; KROHN, SUSANNE, DR
To: MORPHOSYS AG
Reel/Frame 031798/0252 →
Assignment of Assignor's Interest
Dec 18, 2013
From: AMERSDORFFER, JUTTA, DR; STEIDL, STEFAN, DR; WINDERLICH, MARK, DR; KROHN, SUSANNE, DR
To: MORPHOSYS AG
Reel/Frame 031806/0723 →
Excerpt of Commercial Register Reflecting New Address
May 26, 2017
From: MORPHOSYS AG
To: MORPHOSYS AG
Reel/Frame 042587/0014 →
Assignment of Assignor's Interest
Nov 21, 2017
From: ENDELL, JAN; BOXHAMMER, RAINER; WINDERLICH, MARK
To: MORPHOSYS AG.
Reel/Frame 044192/0556 →
Assignment of Assignor's Interest
Feb 12, 2018
From: ENDELL, JAN; WINDERLICH, MARK; BOXHAMMER, RAINER
To: MORPHOSYS AG.
Reel/Frame 044899/0119 →
Assignment of Assignor's Interest
Jan 14, 2019
From: ENDELL, JAN; WINDERLICH, MARK; BOXHAMMER, RAINER
To: MORPHOSYS AG.
Reel/Frame 047986/0882 →
Assignment of Assignor's Interest
Apr 17, 2019
From: ENDELL, JAN; KELEMEN, PETER; BOXHAMMER, RAINER; PETROPOULOS, KONSTANTIN
To: MORPHOSYS AG.
Reel/Frame 048912/0961 →
Assignment of Assignor's Interest
Jun 11, 2019
From: GARIDEL, PATRICK; LANGER, ANDREAS; HESSLING, MARTIN; WEINFURTNER, DANIEL
To: MORPHOSYS AG.
Reel/Frame 049432/0950 →
Assignment of Assignor's Interest
Nov 22, 2019
From: KELEMEN, PETER; WINDERLICH, MARK; WEINELT, DOMINIKA; HEEGER, STEFFEN
To: MORPHOSYS AG.
Reel/Frame 051088/0277 →
Assignment of Assignor's Interest
Mar 13, 2020
From: ENDELL, JAN; BOXHAMMER, RAINER; WINDERLICH, MARK
To: MORPHOSYS AG.
Reel/Frame 052109/0352 →
Assignment of Assignor's Interest
Apr 7, 2020
From: AMERSDORFFER, JUTTA; STEIDL, STEFAN; WINDERLICH, MARK; KROHN, SUSANNE
To: MORPHOSYS AG.
Reel/Frame 052331/0316 →
Assignment of Assignor's Interest
Apr 7, 2020
From: AMERSDORFFER, JUTTA; STEIDL, STEFAN; WINDERLICH, MARK; KROHN, SUSANNE
To: MORPHOSYS AG.
Reel/Frame 052331/0236 →
Assignment of Assignor's Interest
Dec 1, 2020
From: AMBARKHANE, SUMEET; WEIRATHER, JOHANNES
To: MORPHOSYS AG
Reel/Frame 054501/0383 →
Assignment of Assignor's Interest
Feb 19, 2021
From: PRETSCHER, DOMINIK
To: MORPHOSYS AG
Reel/Frame 055345/0488 →
Assignment of Assignor's Interest
Feb 19, 2021
From: ENDELL, JAN; BOXHAMMER, RAINER
To: MORPHOSYS AG
Reel/Frame 055333/0924 →
Assignment of Assignor's Interest
Dec 16, 2021
From: ENDELL, JAN; WINDERLICH, MARK; BOXHAMMER, RAINER
To: MORPHOSYS AG.
Reel/Frame 058407/0955 →
Assignment of Assignor's Interest
Mar 23, 2022
From: GARIDEL, PATRICK; LANGER, ANDREAS; HESSLING, MARTIN; WIENFURTNER, DANIEL
To: MORPHOSYS AG.
Reel/Frame 059375/0008 →
Assignment of Assignor's Interest
May 26, 2022
From: ENDELL, JAN; WINDERLICH, MARK; BOXHAMMER, RAINER
To: MORPHOSYS AG
Reel/Frame 060026/0708 →
Assignment of Assignor's Interest
Sep 2, 2022
From: ENDELL, JAN; FRICK, STEFANIE
To: MORPHOSYS AG.
Reel/Frame 060981/0076 →
Assignment of Assignor's Interest
Sep 21, 2022
From: KUFFER, CHRISTIAN; FINGERLE-ROWSON, GÜNTER; WINDERLICH, MARK; ENDELL, JAN
To: MORPHOSYS AG.
Reel/Frame 061167/0889 →
Assignment of Assignor's Interest
Jan 19, 2023
From: HÄRTLE, STEFAN; STRIEBEL, FRANK
To: MORPHOSYS AG.
Reel/Frame 062423/0970 →
Assignment of Assignor's Interest
Feb 23, 2023
From: ENDELL, JAN; BOXHAMMER, RAINER; WINDERLICH, MARK
To: MORPHOSYS AG.
Reel/Frame 062783/0662 →
Assignment of Assignor's Interest
Jan 15, 2024
From: AMERSDORFFER, JUTTA; STEIDL, STEFAN; WINDERLICH, MARK; WIEGEL (FORMERLY KROHN), SUSANNE
To: MORPHOSYS AG
Reel/Frame 066120/0017 →